Clinical trial
Gastrectomy Study: Study to Investigate the Effect of Creon 25000…
NCT00160186 · Solvay Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00160186 |
|---|---|
| Title | Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy |
| Official title | Double-Blind, Multicenter, Randomized, Placebo-Controlled, Parallel-Group Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After Gastrectomy |
| Lead sponsor | Solvay Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Gastrectomy |
| Intervention type | Drug |
| Interventions | Pancreatin, Placebo |
| Enrollment | 40 |
| Start date | Dec 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Mar 31, 2008 |
| Countries | Denmark, Finland, Norway, Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: